Anisimov VN, Bondarenko LA, Khavinson VKh
If someone has a history of restrictive eating, they are someone who should not take GLP-1 drugs
Its role is to: Enhance insulin secretion when blood sugar rises Reduce glucagon secretion , lowering blood glucose production Slow stomach emptying , which promotes satiety Reduce appetite , leading to weight loss Since natural GLP-1 breaks down quickly, drug companies created synthetic GLP-1 receptor agonists (like semaglutide in Ozempic/Wegovy) that stay active longer
Therefore, researchers are actively investigating the potential of NNMT inhibitors such as 5-amino-1MQ in experimental models
Glucagon-like peptide 1: an introduction and possible implications for neuropsychiatry
Who Should Avoid It Uncontrolled hypertension Cardiovascular disease Use of nitrate medications Pregnancy or breastfeeding Stop Right Away If You Notice Severe or persistent nausea/vomiting Significant blood pressure drop or dizziness Chest pain or irregular heartbeat Severe headache or vision changes Prolonged erection exceeding 4 hours Milder Signs to Watch For How Long Should a PT-141 Cycle Last